Navigation Links
Hahn Dbl Hue

ProductsHahn Dbl Hue
Company Richmond Products, Inc.
Item Hahn Dbl Hue
Features Inquire
Description These color vision tests have been designed by Dr Hahn for the screening, classifying the type and estimating the grade of color deficiency. These plates are designed to measure Red, Green, Blue, Yellow. They provide classification of strong, medium and mild color deficiencies. Screening is accomplished using the initial 12 plates. Nine diagnostic plates use numbers and winding lines. Total plates for type A and B is 21 plates.

The tests were designed according to the Pitts and Judds Isocolor Theories for color defectives using the C.I.E. chromaticity diagram and Standard color paper (JIS Z8721-1964). Clinical testing over the past 12 years has shown that these Isochromatic tests yield a more accurate results compared to the Ishihara tests which were designed in 1917.. Dr Ohta has shown the misdiagnosis of the Ishihara test to exceed 12%. Further, the Ishihara test only tests for Red/Green and does not categorize the defect to strong, medium or mild defect.

Info Richmond Products, Inc.Call Richmond Products, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-435-4770

Customer Service: 505-275-2406
Web site: http://www.richmondproducts.com

Related medicine products :

1. LAnthonys Desaturated 15 Hue Test
2. LAnthony New Color Test 100 Hue Test
3. LAnthony 40 Hue Test
4. LAnthony New
5. LAnthony 40
Select Support Brief...
For Dermolipectomy or Lipoplasty of upper arms, Lipoplasty of anterior and lateral axillary folds/rolls...
Short-Sleeve Bolero for targeted compression in the upper arms, back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
Medicine Products:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: